-
Mashup Score: 5
In addition to their role in promoting feeding and obesity development, hypothalamic arcuate agouti-related protein/neuropeptide Y (AgRP/NPY) neurons …
Source: www.sciencedirect.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Background Visit-to-visit body weight variability (BWV), pulse rate variability (PRV), and blood pressure variability (BPV) have been respectively linked to multiple health outcomes. The associations of the combination of long-term variability in physiological measures with mortality and epigenetic age acceleration (EAA) remain largely unknown. Methods We constructed a composite score of…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
New research - https://t.co/7Y5gcs5RiA Larger variability in physiological measures** associated with a higher risk of mortality and faster #epigenetic #aging **measures = #bodyweight #pulserate #bloodpressure #cardiotwitter #primarycare #GPtwitter https://t.co/nrkwRhLDUV
-
-
Mashup Score: 43Tirzepatide: a new low for bodyweight and blood glucose - 1 year(s) ago
The normal incretin effect—an enhanced prandial insulin response—is mediated mostly by meal-stimulated release of the intestinal hormones GLP-1 and glucose-dependent insulinotropic peptide (GIP).1 Analogues of GLP-1 that act as GLP-1 receptor agonists are established glucose-lowering agents that potentiate insulin release and suppress glucagon in a glucose-dependent manner. GLP-1 receptor…
Categories: Healthcare Professionals, Latest HeadlinesTweet-
RT @TheLancetEndo: #Tirzepatide: a new low for #bodyweight and blood #glucose https://t.co/Mr5SldRSGp #T2D #obesity #IDF2022 https://t.co/z…
-
-
Mashup Score: 7Tirzepatide: a new low for bodyweight and blood glucose - 1 year(s) ago
The normal incretin effect—an enhanced prandial insulin response—is mediated mostly by meal-stimulated release of the intestinal hormones GLP-1 and glucose-dependent insulinotropic peptide (GIP).1 Analogues of GLP-1 that act as GLP-1 receptor agonists are established glucose-lowering agents that potentiate insulin release and suppress glucagon in a glucose-dependent manner. GLP-1 receptor…
Categories: Endocrinology, Latest HeadlinesTweet-
#Tirzepatide: a new low for #bodyweight and blood #glucose https://t.co/Mr5SldRSGp #T2D #obesity #IDF2022 https://t.co/zy7a2wDYMZ
-
-
Mashup Score: 0Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history - 1 year(s) ago
The life history theory assumes that all organisms are under selective pressure to harvest external resources and allocate them to maximise fitness: only organisms making the best use of energy obtain the greatest fitness benefits. The trade-off of energy spans four functions: maintenance, growth, reproduction, and defence against pathogens. The innovative antihyperglycaemic agents glucagon-like…
Categories: Endocrinology, Latest HeadlinesTweet-
"The innovative antihyperglycaemic agents glucagon-like peptide 1 (#GLP-1) receptor agonists & sodium-glucose cotransporter 2 (#SGLT2) inhibitors decrease #bodyweight & have the potential to counter low-grade #inflammation" https://t.co/FdnQiansXL #diabetes #obesity #LifeHistory
-
-
Mashup Score: 0Tirzepatide: a new low for bodyweight and blood glucose - 2 year(s) ago
The normal incretin effect—an enhanced prandial insulin response—is mediated mostly by meal-stimulated release of the intestinal hormones GLP-1 and glucose-dependent insulinotropic peptide (GIP).1 Analogues of GLP-1 that act as GLP-1 receptor agonists are established glucose-lowering agents that potentiate insulin release and suppress glucagon in a glucose-dependent manner. GLP-1 receptor…
Categories: Endocrinology, Latest HeadlinesTweet-
For more on #tirzepatide see Clifford J Bailey's comment from last year: #Tirzepatide: a new low for #bodyweight and blood #glucose https://t.co/Mr5Sle9u4Z #T2D #obesity https://t.co/224Pb1nwsm
-
-
Mashup Score: 0Multimodal telemonitoring may aid in weight loss for patients with sleep apnea, obesity - 2 year(s) ago
Multimodal telemonitoring may aid in weight loss efforts by patients with obstructive sleep apnea and obesity, according to a study published in Chest.“The present study shows that among obstructive sleep apnea patients with obesity, implementation of a remote feedback program on multimodal self-monitored data can enhance body weight reduction compared to feedback on CPAP adherence
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Among patients with #OSA and #obesity, multimodal telemonitoring may aid in #bodyweight reduction efforts, according to results published in @Journal_CHEST @EndocrineToday https://t.co/Vg56uHI92F
-
-
Mashup Score: 2Multimodal telemonitoring may aid in weight loss for patients with sleep apnea, obesity - 2 year(s) ago
Multimodal telemonitoring may aid in weight loss efforts by patients with obstructive sleep apnea and obesity, according to a study published in Chest.“The present study shows that among obstructive sleep apnea patients with obesity, implementation of a remote feedback program on multimodal self-monitored data can enhance body weight reduction compared to feedback on CPAP adherence
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Among patients with #OSA and #obesity, multimodal telemonitoring may aid in #bodyweight reduction efforts, according to results published in @Journal_CHEST @EndocrineToday https://t.co/F97ZcEHaKh
-
-
Mashup Score: 5
In a longitudinal analysis, William Johnson and colleagues examine how individual lifetime BMI trajectories among white citizens of the UK have changed from 1946 to 2014.
Source: journals.plos.orgCategories: General Medicine News, Latest HeadlinesTweet-
Neither genetics nor #socialbackground is a very good predictor of your #bodyweight @ConversationEDU @PLOSGenetics https://t.co/b1hAA9xE6L https://t.co/Ois5R0OQdJ
-
-
Mashup Score: 0June 2022 - Endocrine News - 2 year(s) ago
Cover Story By Derek Bagley For years, obesity was thought to have the ability to thwart the occurrence of osteoporosis, especially in men. However, a new study in The Journal of Clinica… Read MoreFeatures Beige Fat Benefits: Q&A with Shingo Kajimura, PhD By Glenda Fauntleroy Shaw Endocrine News talks to Shingo Kajimura, PhD, the Endocrine Society’s 2022 Richard E. Weitzman Outstanding…
Source: Endocrine NewsCategories: Endocrinology, Latest HeadlinesTweet-
What were your favorite articles in the past issue of @Endocrine_News? Our cover story explores non-invasive #obesity breakthroughs. Our features include new research into #bodyweight and #bone density in men and new insights into #weight control options: https://t.co/Dck8tDmZAW https://t.co/eQUCgWjG0b
-
#AgRPneurons in the hypothalamus may not be essential for maintaining #bodyweight @CellReports https://t.co/zDMzNCkEDV https://t.co/HNtaUNzNgN